Literature DB >> 241532

Salivary excretion of amobarbital in man.

T Inaba, W Kalow.   

Abstract

The concentrations of amobarbital in saliva and serum were determined in 5 normal adults following ingestion of 120 mg of sodium amobarbital. There was excellent linear relationship between amobarbital concentrations in saliva and serum (r = 0.993); salivary levels were 36.1% of serum levels. Since the pH of saliva was generally lower than that of blood in man, the degree of ionization of amobarbital in serum and saliva had to be taken into consideration. Estimation of the protein binding of amobarbital in serum from concentrations of amobarbital in saliva and serum was in good agreement with the in vitro data of equilibrium dialysis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 241532     DOI: 10.1002/cpt1975185part1558

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

Review 1.  Clinical pharmacokinetics of hypnotics.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

Review 2.  Therapeutic drug monitoring in saliva. An update.

Authors:  R K Drobitch; C K Svensson
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

Review 3.  Interpretation of oral fluid tests for drugs of abuse.

Authors:  Edward J Cone; Marilyn A Huestis
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

Review 4.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 5.  Oral absorption and secretion of drugs.

Authors:  C F Speirs
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

6.  Enzyme induction following a single dose of amobarbital in dogs.

Authors:  P A Reilly; T Inaba; D Kadar; L Endrenyi
Journal:  J Pharmacokinet Biopharm       Date:  1978-08

7.  Drug testing in oral fluid.

Authors:  Olaf H Drummer
Journal:  Clin Biochem Rev       Date:  2006-08

8.  Serum and saliva levels of a trimethoprim-sulfamethopyrazine combination in man.

Authors:  A Sardi; M P Vettaro; R Alesina; S Grasso; G Meinardi; I de Carneri; V Tamassia
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Cyclobarbital as a test substance for oxidative drug metabolism in man. Findings in neuropsychiatric patients.

Authors:  U Breyer-Pfaff; H Jerg; F Petruch
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.